Stockpile Inventory Modernization Act of 2020

Bill: 116-hr-6517
Sponsor: full_name: Rep. Brooks, Susan W. [R-IN-5]
Introduced: 2020-04-17
Policy area: Health
Subjects: Congressional oversight

Health technology, devices, supplies

Immunology and vaccination

Intergovernmental relations

Public contracts and procurement

Strategic materials and reserves
Latest action: action_date: 2020-04-17
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2020-04-17
action_desc: Introduced in House
text: <p><b>Stockpile Inventory Modernization Act of 2020</b></p> <p>This bill authorizes the Department of Health and Human Services (HHS) to transfer certain supplies from the Strategic National Stockpile to any federal department or agency on a reimbursable basis, provided that (1) the supplies are less than six months from their expiration date, (2) the stockpile is able to replenish them, and (3) the transfer is in the best interest of the government. </p> <p>HHS shall submit a report to Congress that includes each transfer and the amount reimbursed for the supplies. The authority to make such transfers terminates on September 20, 2023.<br> </p>

tv_txt: I 116th CONGRESS 2d Session H. R. 6517 IN THE HOUSE OF REPRESENTATIVES April 17, 2020 Mrs. Brooks of Indiana (for herself and Ms. Eshoo ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to authorize the transfer to any Federal department or agency, on a reimbursable basis, any drugs, vaccines and other biological products, medical devices, and other supplies in the Strategic National Stockpile, and for other purposes.

1. Short title This Act may be cited as the Stockpile Inventory Modernization Act of 2020 . 2. Reimbursable transfers from Strategic National Stockpile Section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)) is amended by adding at the end the following: (6) Transfers and reimbursements (A) In general Without regard to chapter 5 of title 40, United States Code, the Secretary may transfer to any Federal department or agency, on a reimbursable basis, any drugs, vaccines and other biological products, medical devices, and other supplies in the stockpile if— (i) the transferred supplies are less than six months from expiry; (ii) the stockpile is able to replenish the supplies, as appropriate; and (iii) the Secretary decides the transfer is in the best interest of the United States Government. (B) Use of reimbursement Reimbursement derived from the transfer of supplies pursuant to subparagraph (A) may be used by the Secretary, without further appropriation and without fiscal year limitation, to carry out this section. (C) Report Not later than September 30, 2022, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on each transfer made under this paragraph and the amount received by the Secretary in exchange for that transfer. (D) Sunset The authority to make transfers under this paragraph shall cease to be effective on September 30, 2023. .